Item 8.01 Other Events.
On January 24, 2023, Guardion Health Sciences, Inc. (the "Company") received a
letter from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the
Company's common stock had a closing bid price at or above $1.00 per share for a
minimum of 10 consecutive trading days, the Company had regained compliance with
the minimum bid price requirement of $1.00 per share for continued listing on
The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2).
On January 24, 2023, the Company issued a press release announcing that it had
regained compliance with the minimum bid price requirement of $1.00 per share
for continued listing on The Nasdaq Capital Market. A copy of the press release
is attached as Exhibit 99.1 to this Current Report on Form 8-K and is
incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Exhibit No. Exhibit
99.1 Press release dated January 24, 2023
104 Cover Page Interactive Data File (embedded within the XBRL document)
© Edgar Online, source Glimpses